Two-stage phase II oncology designs using short-term endpoints for early stopping. (2017)
Attributed to:
Adaptive Clinical Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/0962280215585819
PubMed Identifier: 26037529
Publication URI: http://europepmc.org/abstract/MED/26037529
Type: Journal Article/Review
Volume: 26
Parent Publication: Statistical methods in medical research
Issue: 4
ISSN: 0962-2802